Background: The human gut harbors a diverse community of microorganisms which serve numerous important functions for the host wellbeing. Functional foods are commonly used to modulate the composition of the gut microbiota contributing to the maintenance of the host health or prevention of disease. In the present study, we characterized the impact of one month intake of a synbiotic food, containing fructooligosaccharides and the probiotic strains Lactobacillus helveticus Bar13 and Bifidobacterium longum Bar33, on the gut microbiota composition and metabolic profiles of 20 healthy subjects.
Background
Humans can be considered as "superorganisms" with an internal ecosystem of diverse symbiotic microorganisms and parasites that have interactive metabolic processes. Their homeostatic balance is dependent upon the interactions between the host and its microbial components [1] . The human intestine is home to some 100 trillion microorganisms of at least 1000 species. The density of bacterial cells in the colon has been estimated at 10 11 to 10 12 per ml, which makes it one of the most densely populated microbial habitats known [2, 3] . This microbial ecosystem serves numerous important functions for the human host, including protection against pathogens, nutrient processing, stimulation of angiogenesis, modulation of intestinal immune response and regulation of host fat storage [4, 5] . The composition of the adult gastrointestinal microbiota has been intensely studied, using both cultivation and, more recently, culture-independent, small subunit (SSU) ribosomal DNA (rDNA) sequence-based methods [6] [7] [8] .
Members of the anaerobic genera Bacteroides, Eubacterium, Clostridium, Ruminococcus, and Faecalibacterium have typically been found to comprise a large majority of the human adult gut microbial community. In healthy adults, the gut microbiota consists of a stable individual core of colonizing microorganisms surrounded by temporal visitors [9, 10] . Fluctuations around this core of phylotypes are due to host genotype, diet, age, sex, organic disease and drugs (especially antibiotics) [11] . It has been shown that the microbiota structure strongly influences the gut metabolic phenotype [12, 13] . On short time scales, the host-specific effects are relatively constant and changes in the gut microbiome composition and activities are closely influenced by dietary variations.
An increasing awareness of the potential of gut microorganisms to influence human health has led to widespread investigation of the relationship between the gut microbiota and nutrients, particularly probiotics [14] and prebiotics [15] and their impact on the digestive system. Members of the genera Bifidobacterium and Lactobacillus, natural components of the colonic microbiota, are the most commonly used probiotic bacteria in many functional foods and dietary supplements [16] . Postulated health advantages associated to bifidobacteria and lactobacilli include the inhibition of pathogenic microorganisms, improvement of lactose digestion, reduction of serum cholesterol levels, prevention of cancer and enhancement of the host's immune system [17, 18] . Several oligosaccharides have been studied as potential prebiotics, including lactulose, galactooligosaccharides and fructooligosaccharides (FOS) [19] . Dietary supplements of prebiotics increase the content and proportion of bifidobacteria [20] and exert positive effects on absorption of nutrients and minerals, synthesis of vitamins, prevention of constipation, colon cancer, and improvement of blood sugar and lipid profile [21] . Another possibility in the microbiota modulation is the use of synbiotics, in which probiotics and prebiotics are used in combination. This combination improves the survival of the probiotic strains, because specific substrates are readily available for their fermentation, and results in advantages to the host that the live microorganisms and prebiotics offer [11] .
The inadequacy of conventional culture techniques to reflect the microbial diversity of the intestinal ecosystem has triggered the development of culture-independent 16S rRNA gene-based techniques for the evaluation of the effects of functional food administration in humans [22, 23] . The latest frontier in the characterization of uncultured and complex microbial communities is the high-throughput technology of pyrosequencing, which achieves hundreds of thousands of sequences of a specific variable region within the small subunit of rRNA gene, consequently revealing the full diversity of an ecosystem [24, 25] . However, since this approach is extremely labor intensive and time consuming, PCR-DGGE and real-time PCR represent population fingerprinting methods, commonly used to analyze the intestinal microbiota upon dietary intervention. PCR-DGGE allows the visualization of the predominant genetic diversity without prior knowledge of the composition or complexity of the microbial ecosystem present in the sample [23, 26] . Real-time PCR enables specific intestinal bacterial populations to be directly quantified by using DNA isolated from fecal material [23, [27] [28] [29] .
Gene expression profiling and proteomic approaches have been applied to elucidate the molecular mechanisms underlying symbiotic host-bacterial relationships [30] [31] [32] . However, gene expression and proteomic data might only indicate the potential for physiological changes because many pathway feedback mechanisms are simply not reflected in protein concentration or gene expression. On the other hand, metabolite concentrations and their kinetic variations in tissues or biological matrixes represent real end-points of physiological regulatory processes [1, 33] . Metabonomics is defined as "the quantitative measurement of the dynamic multiparametric metabolic response of living systems to pathophysiological stimuli or genetic modification" [34] . Metabonomics provides a systems approach to understand global metabolic regulation of an organism and its commensal and symbiotic partners [1] . Recently, complementary metabonomic approaches have been employed for the biochemical characterization of metabolic changes triggered by gut microbiota, dietary variation and stress interactions [35] [36] [37] [38] [39] . Solid phase microextraction followed by gaschromatography and mass spectrometry represents a novel method for studying metabolic profiles of biological samples. This approach has been used to compare neonates and adult feces [40] and to identify volatile markers of gastrointestinal disease [41] .
In the present study, we characterized the impact of the intake of a synbiotic snack on the gut microbiota composition and metabolic profiles of healthy subjects. The synbiotic snack contained the substrate FOS, whose prebiotic effects are widely documented [42] , and the probiotic strains Lactobacillus helveticus Bar13 and Bifidobacterium longum Bar33, which were selected on the basis of their adhesion and immune-regolation properties, as assessed by both in vitro [43] and in vivo studies on animal models [44] . Co-variations were searched between the gut microbiome structure, as reflected by community DNA fingerprints derived from PCR-DGGE and real-time PCR data, and host metabolic phenotypes, as detected by GC-MS/ SPME.
Results
Effects of the synbiotic food on composition of the gut microbiota PCR-DGGE analysis with universal primers targeting the V2-V3 region of the 16S rRNA gene was used to monitor the impact of the synbiotic food intake on the predominant bacterial population ( Figure 1A ). Population fingerprint profiles were compared and numerically analyzed by FPQuest Software. DGGE band profiles (mean of bands: 15.3) were stable for each subject over a month of feeding with the functional food. Only a slight difference in band richness was found between the time points of the study (T0, mean of bands: 15.8; T1, mean of bands: 14.8). DGGE bands were subjected to Mann-Whitney U-test in order to search for significant differences in the intensities between T0 and T1. No band showed a significant variation, indicating that the consumption of the synbiotic food did not alter the concentration of any major species of intestinal microbiota. Pearson correlation was used to calculate the similarity index (SI) between DGGE band profiles related to the time points T0 and T1 for each healthy volunteer ( Table 1 ). The high median value of SI (67.1%) revealed that the dominant bacterial composition remained constant over the treatment. Only 3 subjects presented SIs lower than 50% (subjects 8, 12 and 20) . No subject showed significant variations between DGGE band profiles related to T0 and T1, as evaluated using the Pearson correlation analysis (P > 0.05).
Cluster analysis of DGGE population profiling confirmed the stability of the overall structure of the microbiome, revealing no grouping according to the feeding ( Figure 1B -C). T0 and T1 banding patterns were closely related for all the volunteers, except for the subject 8 (SI: 47.7%). Among different subjects, considerable variation in the composition of the population fingerprints could be observed. Both qualitative (presence or absence of a band) or quantitative (variable intensity of a band) variations did occur. These inter-individual variations were higher than changes elicited by the functional food consumed.
Quantitative variations of bifidobacteria and lactobacilli
In order to evaluate the effect of the prebiotic component on modulation of bifidobacteria and lactobacilli populations and the capability of the probiotic bacteria to pass through the gut of the healthy host, quantitative variations of Bifidobacterium and Lactobacillus genera were determined by real-time PCR and compared to the variations of the species B. longum and L. helveticus ( Table 2 ). All volunteers naturally harbored strains belonging to Bifidobacterium and Lactobacillus, as demonstrated by the presence of these genera in all stool samples recovered before the beginning of the feeding trial. B. longum was also found in all healthy subjects at the time point T0, in accordance with previous studies reporting B. longum as one of the major bifidobacterial species in the intestinal microbiota of human adults [29] . Differently, L. helveticus was detected only in 8 subjects at the time point T0, showing a frequency of 40%. L. helveticus is not a normal inhabitant of the intestinal microbiota, but strains belonging to this species are used as starter cultures in the manufacturing of a variety of fermented dairy products, to modulate flavor. Thus, presence of L. helveticus in fecal samples can be related to a diet rich in yogurt and cheese [45] . Table 2 highlights different trends of variation of Bifidobacterium, DGGE analysis of the fecal samples recovered from 20 healthy volunteers (s1-s20) before (T0) and after (T1) one month of the synbiotic intake 
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Lactobacillus, B. longum and L. helveticus concentrations among the subjects enrolled in the trial, suggesting a specific individual response to the dietary intervention. This variability is particularly evident for L. helveticus. In the majority of the volunteers, the synbiotic intake was associated to an increase or to the appearance of this species. In 2 subjects (4 and 9) no variation was found at the time point T1. In 4 subjects (6, 8, 19 and 20) L. helveticus did not appear after the feeding period and in the subject 20 it disappeared at the time point T1. These results indicate that the capability of L. helveticus Bar 13 to persist in the gastrointestinal tract is related to the specific characteristics of the host gut environment.
In order to assess the global impact of the functional food consumption on the bifidobacteria and lactobacilli populations, a statistical elaboration of the real-time PCR data was performed. Box plots in Figure 2 show the amounts of 16S rrn operons of Bifidobacterium (A), B. longum (B), Lactobacillus (C) and L. helveticus (D) detected at the time points T0 and T1 of the feeding study. The intake of the synbiotic food did not cause significant variations in the median value of Bifidobacterium (T0: 2.6 × 10 7 ; T1: 2.2 × 10 7 ), B. longum (T0: 4.7 × 10 6 ; T1: 5.1 × 10 6 ) and Lactobacillus (T0: 8.5 × 10 5 ; T1: 6.5 × 10 5 ). On the contrary, a significant increase (P < 0.05) of L. helveticus DNA was observed after the administration of the functional food (T0 median value: 0; T1 median value: 6.6 × 10 2 ), demonstrating the ability of L. helveticus Bar13 to pass through the gut of healthy humans. The significant increase of L. helveticus was directly linked to the low incidence of this species in the intestine of the human host. Analogously, the absence of significant variations in Bifidobacterium, Lactobacillus and B. longum could be related to the high T0 amounts of these bacterial groups, natural inhabitants of the gut microbiota of healthy humans. Amounts of L. helveticus were evaluated by real-time PCR in stool samples recovered from 10 subjects after a wash-out period of 20 days. Concentration of this species returned to a median value of 0, supporting the hypothesis of a transient persistence of the probiotic strain Bar13 during the feeding period (data not shown). Relationship between B. longum variations (T1/T0 16S rrn operons) and B. longum amount before the feeding trial (T0 16S rrn operons) Figure 3 Relationship between B. longum variations (T1/T0 16S rrn operons) and B. longum amount before the feeding trial (T0 16S rrn operons). Empty circles indicate subjects with T0 value minor or equal to 1.0 × 10 6 16S rrn operons per μg of total bacterial DNA. Filled circles indicate subjects with T0 value higher than 1.0 × 10 6 16S rrn operons per μg of total bacterial DNA.
10 2 ) after the synbiotic intake. The same subject presented the lowest SI (38.2%) between DGGE band profiles related to the time points T0 and T1. These data suggest the capability of B. longum Bar33 to pass through the human gastrointestinal tract, but this property can be detected only in subjects harboring low basal level of B. longum species.
Changes in intestinal metabolic profiles
In this investigation about 130 different metabolites belonging to the families of alcohols, ketones, aldehydes, sulfur compounds, nitrogen compounds and SCFA were detected in feces by means of GC-MS/SPME analysis (see Additional file 1). A two-tailed Mann-Whitney test was performed on the metabolic data matrix in order to identify the molecules significantly affected by the consumption of the functional food. A CAP analysis performed on the selected molecules evidenced that metabolites whose changes were positively correlated with the synbiotic administration principally belonged to the families of ketones (methyl-5-hepten-2-one, 2-propanone, 2-butanone, 2-pentanone, 2,3-butanedione) and SCFA (acetic and valeric acid). Differently, the concentration of 1-octanol, thiophene and nonanone decreased significantly after the feeding period. These results are showed in the Figure 4 , which reports the loadings plot obtained from the CAP analysis. The scores plot (canonical axe) obtained from the same supervised method showed a perfect classification of the samples, on the basis of the synbiotic food intake ( Figure 5 ). The application of the CAP analysis on metabolites data set characterized by GC-MS/ SPME resulted in classification and predictive abilities of 100% (see Additional file 2), as evaluated by the leavefour-out procedure used, using only a reduced number of experimental chromatographic peaks as input variables.
CAP loadings plot of metabolites whose concentration was significantly affected by the intake of the synbiotic food (P < 0.05) Figure 4 CAP loadings plot of metabolites whose concentration was significantly affected by the intake of the synbiotic food (P < 0.05). Positive and negative coefficients indicate the increase or decrease of metabolite amounts following the feeding period.
Discussion
The significant involvement of the gut microbiota in the human health suggests that modulation of commensal microbial composition and metabolism through combinations of probiotics and prebiotics could be a dietary strategy to prevent diverse diseases, such as obesity, diabetes, non-alcoholic fatty liver disease, inflammatory bowel disease, and even cancers [4] .
In the present study, the impact of a synbiotic food supplement on the gut microbiota structure of healthy humans was evaluated by using an integrated molecular approach based on PCR-DGGE and real-time PCR.
DGGE profiles of the predominant fecal microbiota generated complex but overall relatively stable and unique profiles for each individual. Elaboration of DGGE data revealed high SI values between T0 and T1 profiles, and no clustering of banding patterns according to the feeding. These results demonstrated that no significant change in the structure of the gut microbiota of healthy subjects did occur following dietary intervention, confirming previous findings regarding the subject specificity of the predominant fecal communities and their stability over time and resistance to perturbations [9, 23] . Notably, we cannot exclude an effect of the synbiotic intake on minor bacterial species, an effect that could be investigated using high-CAP scores plot of the stool samples collected from the twenty volunteers before (T0) and after (T1) the synbiotic food intake Figure 5 CAP scores plot of the stool samples collected from the twenty volunteers before (T0) and after (T1) the synbiotic food intake.
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throughput sequencing techniques. However, the impact on the dominant colonic microbiota represents the main parameter to evaluate the clinical relevance for the use of a functional food.
Because DGGE can be considered a semiquantitative tool for monitoring the dynamics of the predominant bacterial species of an ecosystem, additional analysis with real-time PCR was performed to obtain a quantitative estimation of the effect of the synbiotic intake on bifidobacteria and lactobacilli populations. In particular, variations in amounts of B. longum and L. helveticus were evaluated in order to assess the capability of the probiotic species included in the synbiotic food to pass through the gastrointestinal tract of the human host. Only L. helveticus concentration increased significantly after the ingestion of the functional food, demonstrating the gut persistence of the probiotic L. helveticus strain during the feeding period.
Since L. helveticus species is not a natural inhabitant of the human intestine and its presence in feces is diet related [45] , this result was not surprising and suggests that low abundant species could be optimal models for studying the gut colonization of probiotic bacteria. On the other hand, visualization of the gut colonization of a high abundant species, such as B. longum, is strictly related to its basal concentration. For this reason, we observed the B. longum increase only in subjects with the lowest concentration of B. longum species at the time point T0.
The intake of the synbiotic food resulted in significant changes in some gut metabolic activities, as highlighted by the CAP analysis of the fecal metabolic profiles, which pointed out a separation of fecal samples of the subjects on the basis of the synbiotic food intake. Surprisingly little is known about volatile organic compounds formed in the gut. GC-MS/SPME, detecting volatile molecules with high sensitivity, represents a suitable approach to identify microbial metabolites in fecal samples, such as SCFAs, ketones, esters and sulfur compounds [46] .
Two SCFAs, acetic and valeric acids, were the metabolites showing the highest increase after the synbiotic administration. Although a general increase was observed also for butyric acid, this variation was not statistically significant due to the high variability of the measures. SCFAs are very common in the gut environment, arising from metabolism of undigested carbohydrates, such as dietary fiber and prebiotics, by colonic bacteria. The increase of SCFAs is particularly interesting, as they play a role in regulation of cell proliferation and differentiation of the colonic epithelial cells. Increases in SCFA production have been associated with decreased pH, which may reduce potential pathogenic clostridia, decreased solubility of bile acids, increased absorption of minerals, and reduced ammonia absorption by the protonic dissociation of ammonia and other amines [47] . Other metabolites whose changes were positively and significantly correlated with the synbiotic intake belonged to the family of methylketones (methyl-5-hepten-2-one, 2-propanone, 2-butanone, 2-pentanone, 2,3-butanedione). In particular, the significant increase of 2-pentanone can be regarded as the most interesting effect associated with the synbiotic food intake. In fact, 2-pentanone, which is a naturally occurring compound in fruits, vegetables and fermented foods, has anti-inflammatory and chemopreventive properties. According to Pettersson et al. [48] , it inhibits the prostaglandin production and COX-2 protein expression in human colon cancer cells. The increase of 2,3-butanedione is interesting since it may have health benefits by impacting on the growth of some bacteria, such as L. delbrueckii subsp. bulgaricus ad Streptococcus thermophilus [41] . Furthermore, during glucose catabolism 2,3-butanedione serves as an electron acceptor and can be reduced to 2,3-butanediol via acetoin. This pathway was shown to be important in the removal of toxic amounts of pyruvate and in maintenance of pH homeostasis [49] . A diverse range of sulfur compounds has been identified in stool samples [41] . The usual source of sulfur compounds is the microbial breakdown of sulfur containing amino acids and the increase of these compounds suggests an abundance or metabolic activity of bacteria able to breakdown cystein and methionine. In our study, a significant increase of carbon disulfide was observed following the feeding period. Carbon disulfide may be produced by carbonation of hydrogen sulphide as a detoxification mechanism exerted by colonic bacteria. According to Garner et al. [41] , carbon disulfide has been found in 100% of the samples from healthy donors and absent in many samples of patients with Campylobacter jejuni and Clostridium difficile. Various esters were detected in all fecal samples. In particular, a significant increase of methyl acetate, ester of methanol and acetic acid, was evident after the synbiotic intake. Methanol is rarely found as free alcohol in the gut, where it is generated from the breakdown of macromolecules including pectins, bran and aspartame. In general, free alcohols and endogenous fatty acids are metabolized into fatty acid esters in liver, pancreas and intestine [50] . At the intestinal site, esterification of alcohols by colonic bacteria can be regarded as a microbial strategy to remove or trap toxic molecules such as fatty acids and alcohols.
To sum up, the investigation of the fecal volatile metabolites by GC-MS/SPME allowed to correlate the consumption of the synbiotic food with the stimulation of healthpromoting metabolic activities of the gut microbiota, such as regulation of the colonic epithelial cell proliferation and differentiation, anti-inflammatory and chemopreventive properties and detoxification processes.
Conclusion
In the current study molecular fingerprinting techniques (PCR-DGGE and real-time PCR) were integrated to the GC-MS/SPME analysis of the metabolic profiles to investigate the global impact of a dietary intervention on the gut ecology and metabolism in healthy humans. In particular, the major findings of this study are the following: (i) the synbiotic food does not modify the overall structure of the gut microbiome, as detected by DGGE; (ii) the gut survival of the probiotic strains may be supposed on the basis of the increase of B. longum and L. helveticus after the synbiotic consumption; (iii) the perturbation of the gut metabolism triggered by a synbiotic food intake generates significant changes in the GC-MS/SPME profiles; (iv) changes in metabolic phenotypes seem to indicate potential implications of the synbiotic food in health maintenance and prevention of diverse diseases.
In order to better investigate the mechanistic basis of the probiotics and prebiotics action on gut microbial activities and the outcomes on human health, it will be necessary to integrate the GC-MS/SPME and/or NMR profiles of feces with simultaneous analysis of different biofluids, including urine and plasma.
Methods

Study population
Twenty randomly selected healthy volunteers (11 women and 9 men) aged between 20 and 50 (mean: 35) participated in the study. The Ethics Committee of the University of Bologna (Italy) approved the study, and all subjects gave informed consent. None of the subjects had a history of gastrointestinal or metabolic disease or previous surgery (apart from appendectomy). The subjects did not receive antibiotic treatment or any other medical treatment influencing intestinal microbiota during 3 months before the start of the study. Subjects maintained their usual diet during the study period. All the volunteers had normal weight with a body mass index in the range 18.5-24.9. The volunteers received one dose of a synbiotic snack (Barilla, Parma, Italy), twice a day for a period of 1 month. The synbiotic bar consisted of a biscuit covered by chocolate. The biscuit contained 500 mg of FOS (Actilight ® 950P, Marckolsheim, France) and the chocolate included a mixture of the probiotic strains B. longum Bar33 and L. helveticus Bar13 (Barilla culture collection). 10 9 CFU of each probiotic strain were present in a dose of the synbiotic bar.
Extraction of DNA from fecal samples
Stool samples were collected from volunteers before the start of the feeding study (T0) and at the end of the ingestion period (T1) and immediately frozen at -80°C until use. Total DNA was extracted from 230 mg of feces by using QIAamp DNA Stool Mini Kit (Qiagen, Hilden, Germany), according to the manufacturer's instructions.
PCR-DGGE and cluster analysis
Amplification of the V2-V3 region of the bacterial 16S rRNA gene was carried out using the universal eubacterial primers GCclamp-HDA1 and HDA2 [51] , supplied by MMedical (Milan, Italy). The amplification reactions were performed in a Biometra Thermal Cycler T Gradient (Biometra, Göttingen, Germany [52] . Briefly, the sequence-specific separation of the PCR fragments was obtained in 8% (w/ v) polyacrylamide gels, containing a 30% to 50% gradient of urea and formamide. Electrophoresis was started at a voltage of 250 V for 5 minutes and continued at constant voltage of 90 V and temperature of 60°C for 16 h. Following electrophoresis, the gel was silver stained [53] and scanned using a Molecular Imager Gel Doc XR System (Bio-Rad). DGGE gel images were analyzed using the FPQuest Software Version 4.5 (Bio-Rad). In order to compensate for gel-to-gel differences and external distortion to electrophoresis, the DGGE patterns were aligned and normalized using an external reference ladder, containing PCR amplicons from pure cultures of intestinal bacterial species. A cluster analysis of the DGGE patterns was performed using the FPQuest Software. The similarity in the profiles was calculated on the basis of the Pearson correlation coefficient with the Ward clustering algorithm. [30] and L. acidophilus NCFM [57] . For L. helveticus species the probiotic strain included in the synbiotic was used as standard and the number of rrn operons in the genome was deduced from the sequenced genome of L. helveticus DPC 4571 [58] . Chromosomal DNA of the strains used as standards was extracted by using DNeasy Tissue Kit (Qiagen) and serially diluted from 10 5 to 10 1 molecules/μl. Results obtained by PCR were converted to the average estimate of total rrn operons from each group present in 1 μg of total DNA, and standard deviations (SD) were calculated.
Development of L. helveticus species-specific primers
GC-MS/SPME
A carboxen-polydimethylsiloxane coated fiber (85 μm) and a manual SPME holder (Supelco, Bellefonte, PA) were used in this study after preconditioning according to the manufacturer's instruction manual. Before each head space sampling, the fiber was exposed to the GC inlet for 5 min for thermal desorption at 250°C in a blank sample. Five ml of fecal slurries (20%) were placed in 10 ml glass vials, added with 4-methyl-2-pentanol (4 mg/l) as internal standard. The samples were then equilibrated for 10 min at 45°C. The SPME fiber was exposed to each sample for 40 min and then was inserted into the injection port of the GC for a 5 min sample desorption. GC-MS analyses were performed on an Agilent 7890A gaschromatograph (Agilent Technologies, Palo Alto, CA) coupled to an Agilent 5975C mass selective detector operating in electron impact mode (ionization voltage 70 eV). A Supelcowax 10 capillary column (60 m length, 0.32 mm ID) was used (Supelco). The temperature program was: 50°C for 1 min, then programmed at 4.5°C/min to 65°C and finally at 10°C/min to 230°C which was maintained for 25 min. Injector, interface and ion source temperatures were 250, 250 and 230°C, respectively. The mass-to-charge ratio interval was 30-350 Da at 2.9 scans per second. Injections were performed in splitless mode and helium (1 ml/min) was used as carrier gas. The identification of all the molecules detected in fecal samples was based on comparison of their retention times and spectral data with those of pure compounds (Sigma-Aldrich, Milan, Italy) analyzed in the same conditions. The identification was further confirmed by comparing mass spectra of all compounds with those contained in available databases (NIST version 2005 and Wiley version 1996) and in literature [41] . Quantitative data of the identified compounds were obtained by interpolation of the relative areas versus the internal standard area, in calibration curves built with pure reference compounds. The concentration of volatile compounds, for which there were no pure references, was obtained by using the same calibration graphs of the compounds with the most similar chemical structure.
Statistical analyses
For each subject, variations of the DGGE profiles related to the time points T0 and T1 were analyzed by Pearson correlation. Significant differences in the intensity of each DGGE band among all fecal samples were searched by using Mann-Whitney U-test. Mann-Whitney U-test was also used to analyze differences in total rrn operons of target genera and species and to determine metabolites significantly affected by the synbiotic food intake. A P value below 0.05 was considered statistically significant. Metabolites with a P value below 0.05 were then used in further multivariate analysis. These selected metabolites formed a matrix containing two kinds of information: the effects of the synbiotic food intake (within-individual variability) and the natural differences between individuals (betweenindividuals variability). These two kinds of information were separated following the method of Jansen et al. [59] . A CAP analysis was then performed on the within-individual variability matrix [60] . The CAP constrained ordination procedure can be summarized as follows: the data were reduced by performing a principal coordinate analysis (PCO) on the parameters using a dissimilarity measure based on Euclidean distances; an appropriate number of PCOs were chosen non-arbitrarily, which maximize the number of observations correctly classified [61, 60] . The robustness of the model obtained was established by a 4-fold cross validation method, repeatedly leaving out a fourth of the samples and predicting them back into the model [62] . Finally a traditional canonical analysis on the first three PCOs was performed. The hypothesis of no significant difference in multivariate location among the groups was tested by using a permutation test based on 9999 permutations.
Statistical analyses were performed using the software SigmaStat (Systat Sofware Inc., San Jose, CA) and the package Canoco for Windows 4.5 (Microcomputer Power, Ithaca, NY).
